EWM
GILD icon

Executive Wealth Management’s Gilead Sciences GILD Stock Holding History

Executive Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$249K Buy
2,699
+55
+2% +$4.95K 0.02% 236
2024
Q3 		$222K Buy
+2,644
New +$202K 0.02% 250
2024
Q1 		– Sell
-2,622
Closed -$212K – 247
2023
Q4 		$212K Sell
2,622
-67
-2% -$5.21K 0.02% 206
2023
Q3 		$202K Sell
2,689
-142
-5% -$10.9K 0.02% 193
2023
Q2 		$218K Buy
2,831
+27
+1% +$2.15K 0.02% 189
2023
Q1 		$233K Buy
2,804
+11
+0.4% +$911 0.03% 180
2022
Q4 		$240K Buy
+2,793
New +$221K 0.03% 170
2019
Q3 		– Sell
-594
Closed -$40K – 383
2019
Q2 		$40K Buy
594
+5
+0.8% +$329 0.01% 340
2019
Q1 		$38K Sell
589
-956
-62% -$63.5K 0.01% 313
2018
Q4 		$97K Buy
+1,545
New +$108K 0.02% 204

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Executive Wealth Management's GILD Position: Q4 2024 in Review

Executive Wealth Management increased its Gilead Sciences (GILD) stake by 2.1% in Q4 2024, buying an estimated $4.95K and bringing the position to 2,699 shares worth $249K. The position accounts for 0.02% of the portfolio, ranked #236.

Executive Wealth Management first reported a position in GILD in Q4 2018 and has held it in 10 quarters since. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Executive Wealth Management held 2,699 shares of Gilead Sciences worth $249K as of Q4 2024.
  • Executive Wealth Management bought 55 Gilead Sciences shares in Q4 2024, an estimated $4.95K.
  • Gilead Sciences made up 0.02% of Executive Wealth Management's portfolio in Q4 2024, its #236 holding.
  • Executive Wealth Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 10 quarters since.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Executive Wealth Management's 13F filing for Q4 2024, filed 13 Feb 2025.